Early automated insulin delivery pilot for newly diagnosed T1D

ClinicalTrials.gov recorded a new clinical trial registration (NCT07501338) for a pilot study examining early automated insulin delivery (AID) technology in newly diagnosed Type 1 Diabetes patients. The study is designed as a single-arm feasibility trial to evaluate glycemic control outcomes and user experience with AID systems initiated shortly after diagnosis. Estimated enrollment is 20 participants with a primary completion timeframe of approximately 2 years.\n\nThis is a routine clinical trial registration notice with no new regulatory obligations. Trial sponsors and clinical investigators involved in diabetes device research should ensure their ongoing studies remain properly registered and updated on ClinicalTrials.gov in accordance with FDAAA 801 requirements. No compliance actions are required from this registration notice.